Publication Information

{'id': 'https://openalex.org/W3110661056', 'doi': 'https://doi.org/10.1136/ijgc-2020-esgo.110', 'title': '281 Real-world-data on platinum outcomes after parp inhibitors progression in high grade serous ovarian cancer patients', 'display_name': '281 Real-world-data on platinum outcomes after parp inhibitors progression in high grade serous ovarian cancer patients', 'publication_year': 2020, 'publication_date': '2020-12-01', 'ids': {'openalex': 'https://openalex.org/W3110661056', 'doi': 'https://doi.org/10.1136/ijgc-2020-esgo.110', 'mag': '3110661056'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/ijgc-2020-esgo.110', 'pdf_url': 'https://ijgc.bmj.com/content/ijgc/30/Suppl_4/A60.2.full.pdf', 'source': {'id': 'https://openalex.org/S4363604990', 'display_name': 'Ovarian cancer', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'conference'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'proceedings-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://ijgc.bmj.com/content/ijgc/30/Suppl_4/A60.2.full.pdf', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5020019573', 'display_name': 'A. Plaja Salarich', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210107147', 'display_name': "Institut Català d'Oncologia", 'ror': 'https://ror.org/01j1eb875', 'country_code': 'ES', 'type': 'government', 'lineage': ['https://openalex.org/I4210107147']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Andrea Plaja Salarich', 'raw_affiliation_strings': ['Badalona-Applied Research Group in Oncology (B-Argo)', 'Catalan Institute of Oncology (Ico)-Badalona, Germans Trias I Pujol University Hospital (Hugtip)', 'Medical Oncology Department'], 'affiliations': [{'raw_affiliation_string': 'Catalan Institute of Oncology (Ico)-Badalona, Germans Trias I Pujol University Hospital (Hugtip)', 'institution_ids': ['https://openalex.org/I4210107147']}, {'raw_affiliation_string': 'Badalona-Applied Research Group in Oncology (B-Argo)', 'institution_ids': []}, {'raw_affiliation_string': 'Medical Oncology Department', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5084028783', 'display_name': 'I. Teruel García', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210107147', 'display_name': "Institut Català d'Oncologia", 'ror': 'https://ror.org/01j1eb875', 'country_code': 'ES', 'type': 'government', 'lineage': ['https://openalex.org/I4210107147']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Iris Teruel García', 'raw_affiliation_strings': ['Badalona-Applied Research Group in Oncology (B-Argo)', 'Catalan Institute of Oncology (Ico)-Badalona, Germans Trias I Pujol University Hospital (Hugtip)', 'Medical Oncology Department'], 'affiliations': [{'raw_affiliation_string': 'Badalona-Applied Research Group in Oncology (B-Argo)', 'institution_ids': []}, {'raw_affiliation_string': 'Medical Oncology Department', 'institution_ids': []}, {'raw_affiliation_string': 'Catalan Institute of Oncology (Ico)-Badalona, Germans Trias I Pujol University Hospital (Hugtip)', 'institution_ids': ['https://openalex.org/I4210107147']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5104004296', 'display_name': 'B. Pardo Búrdalo', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210107147', 'display_name': "Institut Català d'Oncologia", 'ror': 'https://ror.org/01j1eb875', 'country_code': 'ES', 'type': 'government', 'lineage': ['https://openalex.org/I4210107147']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Beatriz Pardo Burdalo', 'raw_affiliation_strings': ["Catalan Institute of Oncology (Ico)-Idibell, L'hospitalet", 'Medical Oncology Department'], 'affiliations': [{'raw_affiliation_string': "Catalan Institute of Oncology (Ico)-Idibell, L'hospitalet", 'institution_ids': ['https://openalex.org/I4210107147']}, {'raw_affiliation_string': 'Medical Oncology Department', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5069482220', 'display_name': 'Marta Gil-Martín', 'orcid': 'https://orcid.org/0000-0002-8548-5355'}, 'institutions': [{'id': 'https://openalex.org/I4210107147', 'display_name': "Institut Català d'Oncologia", 'ror': 'https://ror.org/01j1eb875', 'country_code': 'ES', 'type': 'government', 'lineage': ['https://openalex.org/I4210107147']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Marta Gil-Martin', 'raw_affiliation_strings': ["Catalan Institute of Oncology (Ico)-Idibell, L'hospitalet", 'Medical Oncology Department'], 'affiliations': [{'raw_affiliation_string': "Catalan Institute of Oncology (Ico)-Idibell, L'hospitalet", 'institution_ids': ['https://openalex.org/I4210107147']}, {'raw_affiliation_string': 'Medical Oncology Department', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5113925423', 'display_name': 'Josep Maria Piulats Rodriguez', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210107147', 'display_name': "Institut Català d'Oncologia", 'ror': 'https://ror.org/01j1eb875', 'country_code': 'ES', 'type': 'government', 'lineage': ['https://openalex.org/I4210107147']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Josep Maria Piulats Rodriguez', 'raw_affiliation_strings': ["Catalan Institute of Oncology (Ico)-Idibell, L'hospitalet", 'Medical Oncology Department'], 'affiliations': [{'raw_affiliation_string': "Catalan Institute of Oncology (Ico)-Idibell, L'hospitalet", 'institution_ids': ['https://openalex.org/I4210107147']}, {'raw_affiliation_string': 'Medical Oncology Department', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5089649744', 'display_name': 'C. Fina Planas', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210137803', 'display_name': 'Biomedical Research Institute', 'ror': 'https://ror.org/03yr0pg70', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210137803']}, {'id': 'https://openalex.org/I4210107147', 'display_name': "Institut Català d'Oncologia", 'ror': 'https://ror.org/01j1eb875', 'country_code': 'ES', 'type': 'government', 'lineage': ['https://openalex.org/I4210107147']}], 'countries': ['ES', 'US'], 'is_corresponding': False, 'raw_author_name': 'Claudia Fina Planas', 'raw_affiliation_strings': ['Catalan Institute of Oncology (Ico)-Girona, Girona Biomedical Research Institute (Idibgi)', 'Medical Oncology Department'], 'affiliations': [{'raw_affiliation_string': 'Catalan Institute of Oncology (Ico)-Girona, Girona Biomedical Research Institute (Idibgi)', 'institution_ids': ['https://openalex.org/I4210137803', 'https://openalex.org/I4210107147']}, {'raw_affiliation_string': 'Medical Oncology Department', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039696593', 'display_name': 'M.P. Barretina Ginesta', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210137803', 'display_name': 'Biomedical Research Institute', 'ror': 'https://ror.org/03yr0pg70', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210137803']}, {'id': 'https://openalex.org/I4210107147', 'display_name': "Institut Català d'Oncologia", 'ror': 'https://ror.org/01j1eb875', 'country_code': 'ES', 'type': 'government', 'lineage': ['https://openalex.org/I4210107147']}], 'countries': ['ES', 'US'], 'is_corresponding': False, 'raw_author_name': 'María Pilar Barretina Ginesta', 'raw_affiliation_strings': ['Catalan Institute of Oncology (Ico)-Girona, Girona Biomedical Research Institute (Idibgi)', 'Medical Oncology Department'], 'affiliations': [{'raw_affiliation_string': 'Catalan Institute of Oncology (Ico)-Girona, Girona Biomedical Research Institute (Idibgi)', 'institution_ids': ['https://openalex.org/I4210137803', 'https://openalex.org/I4210107147']}, {'raw_affiliation_string': 'Medical Oncology Department', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5027005167', 'display_name': 'Andrea Valencia', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210107147', 'display_name': "Institut Català d'Oncologia", 'ror': 'https://ror.org/01j1eb875', 'country_code': 'ES', 'type': 'government', 'lineage': ['https://openalex.org/I4210107147']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Andrea Gonzalez Valencia', 'raw_affiliation_strings': ['Badalona-Applied Research Group in Oncology (B-Argo)', 'Catalan Institute of Oncology (Ico)-Badalona, Germans Trias I Pujol University Hospital (Hugtip)', 'Statistics Department'], 'affiliations': [{'raw_affiliation_string': 'Badalona-Applied Research Group in Oncology (B-Argo)', 'institution_ids': []}, {'raw_affiliation_string': 'Catalan Institute of Oncology (Ico)-Badalona, Germans Trias I Pujol University Hospital (Hugtip)', 'institution_ids': ['https://openalex.org/I4210107147']}, {'raw_affiliation_string': 'Statistics Department', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5113283583', 'display_name': 'Anna Esteve Gómez', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210107147', 'display_name': "Institut Català d'Oncologia", 'ror': 'https://ror.org/01j1eb875', 'country_code': 'ES', 'type': 'government', 'lineage': ['https://openalex.org/I4210107147']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Anna Esteve Gomez', 'raw_affiliation_strings': ['Badalona-Applied Research Group in Oncology (B-Argo)', 'Catalan Institute of Oncology (Ico)-Badalona, Germans Trias I Pujol University Hospital (Hugtip)', 'Statistics Department'], 'affiliations': [{'raw_affiliation_string': 'Statistics Department', 'institution_ids': []}, {'raw_affiliation_string': 'Badalona-Applied Research Group in Oncology (B-Argo)', 'institution_ids': []}, {'raw_affiliation_string': 'Catalan Institute of Oncology (Ico)-Badalona, Germans Trias I Pujol University Hospital (Hugtip)', 'institution_ids': ['https://openalex.org/I4210107147']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5011663611', 'display_name': 'Margarita Romeo', 'orcid': 'https://orcid.org/0000-0003-1725-8115'}, 'institutions': [{'id': 'https://openalex.org/I4210107147', 'display_name': "Institut Català d'Oncologia", 'ror': 'https://ror.org/01j1eb875', 'country_code': 'ES', 'type': 'government', 'lineage': ['https://openalex.org/I4210107147']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Margarita Romeo Marin', 'raw_affiliation_strings': ['Badalona-Applied Research Group in Oncology (B-Argo)', 'Catalan Institute of Oncology (Ico)-Badalona, Germans Trias I Pujol University Hospital (Hugtip)', 'Medical Oncology Department'], 'affiliations': [{'raw_affiliation_string': 'Badalona-Applied Research Group in Oncology (B-Argo)', 'institution_ids': []}, {'raw_affiliation_string': 'Medical Oncology Department', 'institution_ids': []}, {'raw_affiliation_string': 'Catalan Institute of Oncology (Ico)-Badalona, Germans Trias I Pujol University Hospital (Hugtip)', 'institution_ids': ['https://openalex.org/I4210107147']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 60}, 'biblio': {'volume': None, 'issue': None, 'first_page': 'A60.2', 'last_page': 'A61'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9959, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9959, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10550', 'display_name': 'Ovarian cancer diagnosis and treatment', 'score': 0.9921, 'subfield': {'id': 'https://openalex.org/subfields/2743', 'display_name': 'Reproductive Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11287', 'display_name': 'Cancer Genomics and Diagnostics', 'score': 0.9825, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/progression-free-survival', 'display_name': 'Progression-free survival', 'score': 0.62778586}, {'id': 'https://openalex.org/keywords/olaparib', 'display_name': 'Olaparib', 'score': 0.58162266}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.711627}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.68530357}, {'id': 'https://openalex.org/C207103383', 'wikidata': 'https://www.wikidata.org/wiki/Q3930246', 'display_name': 'Hazard ratio', 'level': 3, 'score': 0.65316254}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.6398523}, {'id': 'https://openalex.org/C2780739268', 'wikidata': 'https://www.wikidata.org/wiki/Q2112244', 'display_name': 'Progression-free survival', 'level': 3, 'score': 0.62778586}, {'id': 'https://openalex.org/C2779962180', 'wikidata': 'https://www.wikidata.org/wiki/Q7083106', 'display_name': 'Olaparib', 'level': 5, 'score': 0.58162266}, {'id': 'https://openalex.org/C50382708', 'wikidata': 'https://www.wikidata.org/wiki/Q223218', 'display_name': 'Proportional hazards model', 'level': 2, 'score': 0.48335642}, {'id': 'https://openalex.org/C44249647', 'wikidata': 'https://www.wikidata.org/wiki/Q208498', 'display_name': 'Confidence interval', 'level': 2, 'score': 0.4013129}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.3398484}, {'id': 'https://openalex.org/C182979987', 'wikidata': 'https://www.wikidata.org/wiki/Q3907241', 'display_name': 'Poly ADP ribose polymerase', 'level': 4, 'score': 0.11009824}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.059827983}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C82381507', 'wikidata': 'https://www.wikidata.org/wiki/Q416878', 'display_name': 'Polymerase', 'level': 3, 'score': 0.0}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/ijgc-2020-esgo.110', 'pdf_url': 'https://ijgc.bmj.com/content/ijgc/30/Suppl_4/A60.2.full.pdf', 'source': {'id': 'https://openalex.org/S4363604990', 'display_name': 'Ovarian cancer', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'conference'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/ijgc-2020-esgo.110', 'pdf_url': 'https://ijgc.bmj.com/content/ijgc/30/Suppl_4/A60.2.full.pdf', 'source': {'id': 'https://openalex.org/S4363604990', 'display_name': 'Ovarian cancer', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'conference'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.83, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4389948617', 'https://openalex.org/W4361281158', 'https://openalex.org/W4281722959', 'https://openalex.org/W3198165388', 'https://openalex.org/W3112954044', 'https://openalex.org/W3000091075', 'https://openalex.org/W2994686985', 'https://openalex.org/W2944461583', 'https://openalex.org/W2938482998', 'https://openalex.org/W2792971967'], 'abstract_inverted_index': {'<h3>Introduction/Background</h3>': [0], 'PARP': [1], 'inhibitors': [2], '(PARPi)': [3], 'maintenance': [4, 68], 'after': [5, 18, 65, 150, 156, 162, 355, 367, 389], 'Platinum': [6], '(Pt)': [7], 'based': [8], 'chemotherapy': [9], '(CT)': [10], 'significantly': [11, 269], 'improves': [12], 'progression-free': [13, 88], 'survival': [14, 89, 93], '(PARPi-PFS)': [15], 'and': [16, 37, 91, 97, 106, 119, 128, 159, 169, 217, 238, 247, 266, 321, 417, 430, 446, 472, 494, 502], 'PFS': [17], 'subsequent': [19], '(ssq)': [20], 'CT': [21, 34, 64, 206, 379], '(PARPi-PFS2)': [22], 'in': [23, 74, 174, 182, 195, 209, 225, 261, 271, 280, 293, 359, 369, 380, 391], 'relapsed': [24], 'high': [25], 'grade': [26], 'serous': [27], 'ovarian': [28], 'cancer': [29], '(HGSOC).': [30], 'Data': [31], 'regarding': [32, 204], 'ssq': [33, 48, 63, 81, 205, 213, 229, 232, 239, 283, 353, 365, 387], 'is': [35], 'scarce,': [36], 'PARPi/Pt': [38], 'crossed': [39], 'mechanisms': [40], 'of': [41, 47, 123, 126, 291, 308, 323, 386], 'resistance': [42], 'may': [43], 'impact': [44], 'on': [45, 53], 'outcome': [46], 'Pt.': [49], 'We': [50, 57], 'provide': [51], 'Real-world-data': [52], 'this': [54, 80], 'issue.': [55], '<h3>Methodology</h3>': [56], 'included': [58], 'HGSOC': [59], 'p': [60, 188, 201, 226, 256, 281, 294, 319, 330], 'treated': [61], 'with': [62, 133, 234, 241, 295], 'progression': [66, 218], 'to': [67, 79, 212, 376, 507], 'PARPi': [69, 149, 260, 342, 356, 368, 390], 'until': [70], '15th': [71], 'Jul': [72], '2020': [73], '3hospitals.': [75], 'Endpoints': [76, 203], 'were': [77, 101, 131, 140, 244, 268], 'related': [78], 'CT:': [82], 'objective': [83], 'response': [84, 222], 'rate': [85], '(ORR),': [86], 'median(m)': [87], '(PFS)': [90], 'overall': [92], '(OS).': [94], 'Multivariate': [95], 'Cox': [96], 'logistic': [98], 'regression': [99], 'models': [100], 'adjusted': [102], 'by': [103, 287], 'BRCA': [104, 288], 'status': [105], 'Pt-free': [107, 230], 'interval': [108], '(PFI)': [109], '(6–12': [110], 'months(mo)': [111], 'vs': [112, 185, 198, 275, 297], '≥12': [113], 'mo).': [114], 'Adjusted': [115], 'hazard': [116], 'ratios': [117, 121], '(aHR)': [118], 'odds': [120], '(aOR)': [122], 'the': [124, 175, 262, 272, 276, 338, 360, 370, 381, 392], 'risk': [125], 'progression/death': [127], 'ORR,': [129], 'respectively,': [130], 'reported': [132], '95%': [134], 'confidence': [135], 'intervals': [136], '(CI).': [137], '<h3>Results</h3>': [138], '56p': [139], 'identified': [141], '(32p': [142], 'BRCAmut;': [143], '1p': [144], 'BRIP1mut).': [145], '4p': [146, 339], '(7.1%)': [147], 'received': [148, 167, 228, 259, 341], '1st': [151, 344], 'line': [152, 158], 'CT,': [153, 231], '26': [154, 160], '(46.4%)': [155, 161], '2nd': [157], '≥3rd': [163], 'line.': [164, 345], '34p': [165], '(60.7%)': [166], 'olaparib': [168], '22': [170], '(39.3%)': [171], 'niraparib.': [172], 'm-PARPi-PFS': [173], 'recurrent': [176, 263], 'setting': [177], 'was': [178, 191, 215, 300, 314, 325, 357, 374], '7.5': [179], 'mo': [180, 193, 243, 299], '(longer': [181, 194], 'BRCAmut:': [183, 196], '10.1': [184], '5.5': [186], 'mo,': [187, 200, 237], '0.03).': [189], 'm-PARPi-PFS2': [190], '15.8': [192], '20.9': [197], '15.4': [199], '0.07).': [202], 'are': [207], 'shown': [208], 'table1.': [210], 'ORR': [211, 224, 292], 'Pt': [214, 233, 240, 354, 366, 388], '33.3%': [216], 'disease': [219], 'without': [220], 'any': [221], '28.6%.': [223], 'who': [227, 340], 'PFI': [235, 371, 393], '6–12': [236, 298, 372, 394], 'PFI≥12': [242, 273, 296, 361], '33.3%,': [245], '23.8%': [246], '42.8%,': [248], 'respectively.': [249], 'Five': [250], 'complete': [251], 'responses': [252], 'occurred': [253], 'among': [254], 'BRCAmut': [255], 'that': [257], 'had': [258], 'setting.': [264], 'mPFS': [265, 309], 'mOS': [267, 324], 'longer': [270], 'subgroup': [274, 373, 395], 'others': [277], '(figure1).': [278], 'Focusing': [279], 'receiving': [282], 'Pt,': [284], 'when': [285, 336], 'adjusting': [286], 'status:': [289], 'aOR': [290], '0.56': [301], '(95%': [302, 316, 327], 'CI:': [303, 317, 328], '0.13': [304], '–': [305], '2.30),': [306], 'aHR': [307, 322], 'between': [310], 'these': [311], 'two': [312], 'subgroups': [313], '0.61': [315], '0.30–1.20;': [318], '0.16),': [320], '0.20': [326], '0.7–0.61,': [329], '0.005).': [331], 'Results': [332], 'did': [333], 'not': [334], 'change': [335], 'excluding': [337], 'as': [343], '<h3>Conclusion</h3>': [346], 'A': [347], 'trend': [348], 'towards': [349], 'higher': [350], 'benefit': [351, 377], 'from': [352, 364, 378], 'observed': [358], 'subgroup.': [362, 383], 'Benefit': [363], 'similar': [375], 'non-Pt': [382], 'The': [384], 'role': [385], 'warrants': [396], 'further': [397], 'research.': [398], '<h3>Disclosures</h3>': [399], 'Andrea': [400, 503], 'Plaja:': [401], 'travel': [402, 418, 431, 447, 473, 482, 495], 'grant': [403], 'for': [404], 'attending': [405], 'scientific': [406], 'meeting': [407], '(Roche,': [408, 413, 420, 426, 433, 458, 465, 475, 484], 'Angelini).': [409], 'Marta': [410], 'Gil-Marin:': [411], 'speaking': [412, 425, 464], 'Astra': [414, 427, 459, 466, 477], 'Zeneca,': [415, 428, 442, 450, 460, 467], 'Pharmamar)': [416, 471], 'grants': [419, 432, 448, 474, 483, 496], 'Pharmamar,': [421], 'MSD).': [422], 'Beatriz': [423], 'Pardo:': [424], 'MSD)': [429], 'MSD,': [434, 443, 451, 485], 'GSK).': [435], 'Josep': [436], 'Maria': [437], 'Piulats:': [438], 'advisory': [439, 456, 490], 'board': [440, 457], '(Astra': [441, 449], 'Clovis,': [444], 'BeiGene)': [445], 'BeiGene).': [452], 'María': [453], 'Pilar': [454], 'Barretina:': [455], 'GSK,': [461, 468, 476], 'Clovis': [462, 469], 'Oncology),': [463], 'Oncology,': [470], 'Zenaca,': [478], 'Pharmamar).': [479], 'Clàudia': [480], 'Fina:': [481], 'Pfizer,': [486], 'Bristol-Myers)': [487], 'Margarita': [488], 'Romeo:': [489], 'boards': [491], '(AZ,': [492], 'TESARO)': [493], '(Pfizer).': [497], 'Iris': [498], 'Teruel,': [499], 'Anna': [500], 'Esteve': [501], 'Gonzalez': [504], 'have': [505], 'nothing': [506], 'disclosure.': [508]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3110661056', 'counts_by_year': [], 'updated_date': '2024-12-25T23:34:48.759724', 'created_date': '2020-12-21'}